Legal & General Group Plc Sells 53,134 Shares of Henry Schein, Inc. $HSIC

Legal & General Group Plc decreased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 18.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 235,435 shares of the company’s stock after selling 53,134 shares during the quarter. Legal & General Group Plc’s holdings in Henry Schein were worth $17,794,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. AQR Capital Management LLC lifted its stake in shares of Henry Schein by 47.3% during the 1st quarter. AQR Capital Management LLC now owns 30,402 shares of the company’s stock worth $2,071,000 after purchasing an additional 9,756 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Henry Schein by 1.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company’s stock worth $1,155,000 after purchasing an additional 229 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in shares of Henry Schein during the 1st quarter worth $676,000. Cetera Investment Advisers lifted its stake in shares of Henry Schein by 12.9% during the 2nd quarter. Cetera Investment Advisers now owns 5,561 shares of the company’s stock worth $406,000 after purchasing an additional 637 shares during the last quarter. Finally, First Trust Advisors LP lifted its stake in shares of Henry Schein by 0.8% during the 2nd quarter. First Trust Advisors LP now owns 221,130 shares of the company’s stock worth $16,154,000 after purchasing an additional 1,669 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Trading Down 0.2%

Henry Schein stock opened at $76.40 on Tuesday. The stock has a 50-day moving average of $74.49 and a two-hundred day moving average of $75.85. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.75 and a current ratio of 1.36. Henry Schein, Inc. has a one year low of $61.94 and a one year high of $89.29. The stock has a market cap of $8.70 billion, a PE ratio of 23.08, a price-to-earnings-growth ratio of 1.92 and a beta of 0.82.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.12. The business had revenue of $3.37 billion for the quarter, compared to analyst estimates of $3.34 billion. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The company’s revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the company earned $1.15 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. On average, research analysts anticipate that Henry Schein, Inc. will post 5.32 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Robert W. Baird set a $97.00 price objective on Henry Schein in a research note on Wednesday, May 6th. JPMorgan Chase & Co. upped their price objective on Henry Schein from $78.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 25th. Weiss Ratings restated a “hold (c+)” rating on shares of Henry Schein in a research note on Monday, May 4th. Morgan Stanley reiterated an “underweight” rating and issued a $64.00 price target (up from $61.00) on shares of Henry Schein in a research note on Friday, April 24th. Finally, Wall Street Zen cut Henry Schein from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 26th. Six equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $86.83.

Insiders Place Their Bets

In other news, Director Philip A. Laskawy sold 2,844 shares of the stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $80.36, for a total value of $228,543.84. Following the transaction, the director directly owned 21,961 shares of the company’s stock, valued at approximately $1,764,785.96. This represents a 11.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Thomas C. Popeck sold 1,355 shares of the stock in a transaction dated Thursday, March 19th. The shares were sold at an average price of $72.79, for a total value of $98,630.45. Following the completion of the transaction, the chief executive officer directly owned 86,182 shares in the company, valued at $6,273,187.78. This represents a 1.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 12,968 shares of company stock valued at $1,030,477. Insiders own 0.89% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.